The “AIG effect” has hit the pharmaceutical meetings sector. During a closed-door summit for senior-level corporate planners at the Pharmaceutical Meeting Management Forum, participants pointed out that although the pharmaceutical industry is way ahead of the curve in terms of implementing business practices in meetings, the public perception of incentives and corporate events is spilling over into the medical niche. In addition to the perception issue, pharmaceutical companies face
How Pharma Meeting Planners Are Countering the AIG Effect
Pharma planners need to take on a new role: meeting advocates.